Back to today’s briefing

Story perspectives

New Study Reveals Way to Enhance Cancer Immunotherapy

3/19/2025

42 3

Summary

Story summary

A groundbreaking study from St. Jude Children’s Research Hospital uncovers that blocking the protein VDAC2 can significantly boost tumor responses to immunotherapy. By silencing this signal jammer, cancer cells face increased death and inflammation, rendering tumors more vulnerable to treatment. This pivotal research could pave the way for innovative therapies targeting resistant cancers, especially in children.

1 of 1

Story summary

A groundbreaking study from St. Jude Children’s Research Hospital uncovers that blocking the protein VDAC2 can significantly boost tumor responses to immunotherapy. By silencing this signal jammer, cancer cells face increased death and inflammation, rendering tumors more vulnerable to treatment. This pivotal research could pave the way for innovative therapies targeting resistant cancers, especially in children.